Personal information

Other IDs

Scopus Author ID: 35419805000
ResearcherID: GZK-7700-2022

Activities

Collapse all

Employment (6)

Med. Univ. of Vienna : Vienna , AT

2003-07 to present | Assoc. Prof. , Consultant Surgeon, Colorectal Team (Dept of Surgery, Div of General Surgery)
Employment
Source: Self-asserted source
Michael Bergmann

Medical University of Vienna: Vienna, Vienna , AT

1994-09 to present | since 1994 Principal Investigator; 2010-20: Head of the Surgical Research Lab of the former Clinic of Surgery (Dept. of General Surgery, Div of Visceral Surgery )
Employment
Source: Self-asserted source
Michael Bergmann

Med Univ Vienna : Vienna , Vienna , AT

2000-07 to 2003-07 | Staff Member Div. of General Surgery (Surgery, Division of General Surgery )
Employment
Source: Self-asserted source
Michael Bergmann

Med. Univ Vienna : Vienna , Vienna , AT

1994-09 to 2000-07 | Residency (Surgery)
Employment
Source: Self-asserted source
Michael Bergmann

Med. Univ. Vienna : Vienna , AT

1994-03 to 1994-09 | Research Associate (Oncology )
Employment
Source: Self-asserted source
Michael Bergmann

Mount Sinai School of Medicine: New York, New York , US

1990-09 to 1994-02 | Post Doctoral Fellow (Dept. of Microbiology, Group Prof. Palese )
Employment
Source: Self-asserted source
Michael Bergmann

Education and qualifications (1)

Faculty of Medicine, Karl-Franzens-Universität Graz and University of Vienna : Graz and Vienna , AT

1984-09 to 1990-07 | MD
Education
Source: Self-asserted source
Michael Bergmann

Peer review (23 reviews for 10 publications/grants)

Review activity for Cancer gene therapy. (1)
Review activity for Cell death and differentiation. (2)
Review activity for Cell death and disease. (1)
Review activity for Communications biology. (1)
Review activity for Journal for immunotherapy of cancer. (2)
Review activity for Journal of cancer research and clinical oncology. (1)
Review activity for Journal of hepatology. (1)
Review activity for Molecular cancer (5)
Review activity for Molecular therapy oncolytics. (8)
Review activity for Nature biotechnology. (1)
How many people are using ORCID?